# OnCo record ab-205 (drug). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/drugs/ab-205/>
  a schema:Drug ;
  onco:kind "drug" ;
  schema:identifier "ab-205" ;
  schema:name "AB-205"@en ;
  schema:alternateName "E-CEL cells"@en ;
  schema:description "AB-205 is an experimental allogeneic engineered endothelial cell therapy from Angiocrine Bioscience, in phase 3 trials for hodgkin lymphoma and non-Hodgkin lymphoma; its current status is not stated."@en ;
  schema:url <https://onco.cc/drugs/ab-205/> ;
  schema:dateModified "2026-11-03"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/api/v2/studies/NCT05181540>, <https://clinicaltrials.gov/api/v2/studies/NCT05181540>, <https://clinicaltrials.gov/api/v2/studies/NCT05181540>, <https://clinicaltrials.gov/search?intr=AB-205> ;
  onco:status "phase-3" ;
  onco:tag "pipeline", "ctgov-ingest" ;
  onco:modality "Allogeneic engineered endothelial cell therapy (genetically engineered human umbilical vein endothelial cells)" ;
  onco:cancers <https://onco.cc/cancers/non-hodgkin-lymphoma/> ;
  onco:companies <https://onco.cc/companies/angiocrine-bioscience/> ;
  onco:trials <https://onco.cc/trials/nct05181540/>, <https://onco.cc/trials/nct03925935/> .